Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADCY5 | O95622 | 5/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | ABL2 | P42684 | 1/20 | 0.33 |
| ▸ | IGF1R | P08069 | 2/20 | 0.32 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.30 |
| ▸ | ADK | P55263 | 1/20 | 0.30 |
| ▸ | SAT1 | P21673 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25048259 | 0.81 | ADCY5 (0.30) | ADCY5ABL1EGFRABL2 | |
| SCHEMBL25047658 | 0.81 | ADCY5 (0.33) | ADCY5ABL1EGFRABL2IGF1R | |
| SCHEMBL25047923 | 0.81 | ABL1 (0.41) | ADCY5ABL1EGFRABL2IGF1R | |
| SCHEMBL25048108 | 0.81 | METTL3 (0.39) | ADCY5ABL1EGFRABL2IGF1R | |
| SCHEMBL25048517 | 0.81 | ABL1 (0.40) | ADCY5ABL1EGFRABL2IGF1R | |
| SCHEMBL25049103 | 0.80 | ADK (0.38) | ADCY5ABL1EGFRABL2IGF1R | |
| SCHEMBL25048205 | 0.80 | ABL1 (0.32) | ADCY5ABL1EGFRABL2 | |
| SCHEMBL25047595 | 0.80 | ABL1 (0.32) | ADCY5ABL1EGFRABL2METTL3 | |
| SCHEMBL25046672 | 0.79 | ABL1 (0.40) | ADCY5ABL1EGFRABL2IGF1R | |
| SCHEMBL25048840 | 0.79 | ABL1 (0.38) | ADCY5ABL1EGFRABL2IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023017152-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2023-02-16 | — | — | WO | disclosed |